Together we will beat cancer

Donate

Our milestones: the birth of abiraterone for prostate cancer

This entry is part 24 of 30 in the series Our milestones

We look back to the 1990s, and to our ‘first-in-man’ trial of prostate cancer drug abiraterone – a vital step in the drug’s development

Read More

Expert Opinion – treating cancer by exploiting how its DNA is repaired

We spoke to two of our own experts about how they’re targeting fundamental repair processes in our cells to tip cancer cells over the edge.

Read More

Hitting the self-destruct switch – standing up to womb cancer with PARP inhibitors

We take a look at what a new class of drugs called PARP inhibitors are doing to fight womb cancer.

Read More

A disappointing decision over olaparib for ovarian cancer

In light of a preliminary ‘no’ from NICE over olaparib for ovarian cancer, we hear from one of our experts whose work led to the drug’s development

Read More

News digest – new immunotherapy results, ‘personalised vaccines’, an ‘injectable lab’ and more

New immunotherapy results from a big US conference, another first step towards ‘personalised cancer vaccines’, plus what’s an ‘injectable lab’?

Read More

Unpicking the genetic ‘patchwork’ in ovarian cancer

Our researchers are investigating the genetic ‘patchwork’ underlying ovarian tumours, which will lead to more effective treatments in the future.

Read More

Pushing ‘unstable’ pancreatic cancers over the edge

We look at fascinating new research from our scientists showing that pancreatic cancer can be split into four different types.

Read More

Lethal Weapon Too: Using DNA repair processes to target cancer

A Lethal Weapon against cancer? Researchers are using ‘synthetic lethality’ to develop new treatments based on targeting DNA repair processes.

Read More

News digest – Government science funding, exercise and prostate cancer, drug approval and more

Government science funding announcement, exercise and prostate cancer, plus a handful of stories about drug approval – here’s the week’s cancer news.

Read More

NCRI 2014 conference summary – day 4

Here’s our final round-up from the 2014 NCRI cancer conference in Liverpool

Read More